Phase I pharmacokinetic trial of tivantinib: Absorption, distribution, metabolism, and excretion of 14C-labelled tivantinib in healthy male volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2012
At a glance
- Drugs Tivantinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors ArQule; Daiichi Sankyo Inc; Kyowa Hakko Kirin
- 31 Mar 2012 New trial record
- 29 Mar 2012 Results will be presented at AACR-2012 according to an ArQule media release.